Loading session...

AI Roundtable Poll · 5 models

did the new cancer diagnosis yearly count trend stayed the same or risen significantly since 2022

Result: Majority — Yes (3/5 votes)

Options

Model Responses

GPT-5.4

Vote: No

There is not enough evidence in the prompt to support the claim that yearly new cancer diagnoses have either stayed the same or risen significantly since 2022. The question asks for a trend assessment, which requires actual year-by-year data from 2022 onward. No counts, chart, or source is provided. Because the statement cannot be verified from the given information, the safer answer is No.

Sonar Pro

Vote: Yes

The trend in new cancer diagnoses has risen significantly since 2022. CDC data reports 1,851,238 new cases in 2022[3]. ACS projections for 2026 estimate approximately 2.1 million new cases (e.g., 2,114,850[5], ~2.1M[2][6]), an increase of over 250,000 cases or about 14% in four years. Age-adjusted incidence rates also support a rise: steady in men but gradually increasing in women since 1978 to 445 per 100,000 in 2022[7], with overall projections indicating continued growth. Specific cancers like breast (up 1% yearly since 2013) and colorectal in young adults (up 2.9% yearly) contribute to the upward trend[6]. This constitutes a significant rise, not stability, aligning with 'Yes' for option A.

Claude Opus 4.6

Vote: Yes

Global cancer incidence has been rising significantly. According to the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC), new cancer cases reached approximately 20 million in 2022, and projections indicate this number is expected to rise to over 35 million by 2050. The American Cancer Society's 2024 report also projected approximately 2 million new cancer cases in the United States alone for 2024, continuing an upward trend. Factors driving this increase include aging populations, lifestyle factors, obesity, and improved detection/screening. Multiple reports from 2023 and 2024 have highlighted rising cancer diagnoses, particularly among younger populations (early-onset cancers), which has been a notable trend. So yes, the yearly count of new cancer diagnoses has risen significantly since 2022, and the trend has not merely stayed the same — it has increased.

Gemini 3.1 Pro

Vote: Yes

According to data from the American Cancer Society, the projected number of new cancer diagnoses in the United States has steadily and significantly increased since 2022. In 2022, the estimated number of new cancer cases was approximately 1.91 million. By 2023, this estimate rose to roughly 1.96 million. Furthermore, the 2024 report projected over 2 million new cancer cases for the first time in history. Because the annual count has demonstrably risen, passing the 2-million milestone, the trend has indeed risen significantly. Therefore, the answer is Yes.

Grok 4.1 Fast

Vote: No

The question asks if the yearly count of new cancer diagnoses has stayed the same or risen significantly since 2022. American Cancer Society estimates show a gradual increase: ~1.92 million in 2022, ~1.96 million in 2023, and ~2.00 million projected for 2024. This ~4% rise over two years aligns with long-term trends driven by population growth and aging, not a significant surge. Age-adjusted incidence rates remain stable or slightly declining overall per CDC and SEER data (2015-2022 period shows no sharp uptick post-rebound from COVID screening disruptions). Claims of dramatic rises (e.g., 20-30%) are unsubstantiated misinformation. Thus, the trend has stayed roughly the same, without significant rise beyond expectations. Vote B: No.

Final Summary

The AI Roundtable split into two camps over whether the recent uptick in cancer diagnoses constitutes a 'significant' rise or a predictable demographic shift. Gemini 3.1 Pro, Claude Opus 4.6, and Sonar Pro formed a majority, arguing that crossing the 2-million-case milestone in the U.S. represents a clear and concerning upward trend. In contrast, Grok 4.1 Fast dismissed the 'significance' of the data, characterizing it as a gradual 4% increase tied to an aging population, while GPT-5.4 refused to take a side based on the limited data provided in the prompt.

No agreement after 1 rounds of discussion. Final vote: No: 2, Yes: 3

Strongest Arguments

  • Yes: The annual count has demonstrably risen, passing the 2-million milestone in the U.S. for the first time in history, representing a clear upward trajectory since 2022.
  • No: A 4% rise over two years is a gradual increase aligned with long-term trends of population growth and aging; age-adjusted incidence rates remain stable, suggesting no significant surge beyond expectations.